Conagra Brands, Inc. (CAG)

Rating: HOLD

HOLD (5-tier) · balance-sheet repair · conviction: low

EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).

Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.

General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.

Investment Committee Summary

📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.

Rating Bridge

Rating = HOLD because:

• Probability-weighted scenario value implies -6% vs spot
• Monte Carlo median implies -15% vs spot
• DCF fair value implies -90% vs spot — but this is terminal-value sensitive (exit-multiple $1 vs Gordon $15, 985% apart), so it carries less weight
• Bear case (Structural — GLP-1 / Private-Label Erosion) downside is -59% vs spot
• Net: reward/risk of 0.2× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Investment Thesis

At $13.46 (26 June 2026) Conagra trades on 8.2x forward earnings against a packaged-food peer median of 16.6x, carrying a 10.3% indicated dividend yield. The market is pricing a structurally shrinking business with a distressed payout: half the peer multiple implies permanent volume loss to private label and GLP-1 appetite suppression, plus doubt about the dividend given $6.5bn of net debt. The engine's view is less catastrophic but not constructive. The probability-weighted target of $13.20 sits 2% below spot; Monte Carlo puts the probability of upside at 42% with a median outcome of $11.97. The base path, price/mix offsetting soft volume at a 9.3% operating margin, supports roughly $14.6, but a 24% weighting on structural erosion at $5.66 pulls the weighted value back to spot. The rating is therefore HOLD: the discount to peers is real, and so is the impairment risk it compensates for. The single most damaging risk is a forced dividend cut, which would remove the yield support currently holding the price.

The dashboard below is the whole argument on one page: spot ($14) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Anti-Thesis (The Real Bear Case)

The structural case does not require GLP-1 drugs to end packaged food; it requires them to shave one to two points off volume each year while private label takes shelf space in frozen and snacking, Conagra's core aisles. Pricing power has been spent: the 2022-24 inflation rounds pushed price/mix to its elastic limit, so incremental volume decline now flows through a fixed-cost manufacturing base, compressing operating margin towards 6.5%. With $6.5bn of net debt and roughly $670m of dividends paid in FY2025, the balance sheet forces a choice between the payout and brand reinvestment. A cut removes the yield floor, the multiple follows earnings down, and the $5.66 scenario target, below the 52-week low of $12.53, becomes the clearing price.

Key Debate

Gross Margin explains 73% of Monte Carlo outcome variance — the single variable that decides which side is right.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q2): management +0.38 vs analyst floor +0.15 → delta +0.23 (n=23 mgmt / 26 Q&A; 18th pctile across the S&P book, z -1.0).

Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.

News (last 365d, 1000 articles): avg ticker sentiment -0.01 (bullish 12% / bearish 12%)

Scenario Analysis

The tree runs from a structural 'Structural — GLP-1 / Private-Label Erosion' downside ($6) to a 'Bull — Margin Recovery / Re-Rate' bull case ($23); the probability-weighted blend (PWEV $13) is -6% versus spot.

Scenario rationale — what each probability buys (the driver path behind every target):

• Structural — GLP-1 / Private-Label Erosion (24%, $6). Structural impairment — GLP-1 / private-label erosion: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 5.66; probability: 0.24.
• Volume / Cost Recession (18%, $11). Cyclical downturn — packaged-food volume + price/mix vs private-label + GLP-1 + input costs weakens for 1–2 years before normalising. Drivers — implied_target: 10.8; probability: 0.18.
• Base — Price/Mix Offsets Volume (32%, $15). Mid-cycle — normalised packaged-food volume + price/mix vs private-label + GLP-1 + input costs; disciplined capital allocation; steady returns. Drivers — implied_target: 14.63; probability: 0.32.
• Growth — Snacking + Premiumization (18%, $19). Upside — snacking + premiumization + margin recovery lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 18.79; probability: 0.18.
• Bull — Margin Recovery / Re-Rate (8%, $23). Upside tail — sustained tight conditions or a structural re-rate on snacking + premiumization + margin recovery. Drivers — implied_target: 22.91; probability: 0.08.

Valuation Triangulation

Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

DCF, peer P/E re-rate excluded from the weighted blend — diverges >55% from the Monte-Carlo / scenario core. For a high-leverage equity the per-share DCF (enterprise value less large net debt) is hypersensitive to the terminal multiple; a peer re-rate across heterogeneous margins is apples-to-oranges. Shown above for reference; the blend leans on the multiple-discipline and scenario anchors.

Monte Carlo — the distribution, not a point

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $12 and 40% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (73% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 8.0%, 7x terminal FCF multiple → $1. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median forward multiple (P/E 16.56x) implies $27. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.

Across all anchors the spread is 265% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Capital intensity & shareholder returns (ESTIMATE)

Structural risk vs optionality (INFERENCE)

Industry Context — Consumer Staples — Food Bev

This name sits in the Consumer Staples — Food Bev as a packaged_food. packaged-food volume + price/mix vs private-label + GLP-1 + input costs Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: KO (beverages) · PEP (beverages) · MNST (beverages) · MDLZ (packaged_food) · KDP (beverages) · HSY (packaged_food) · KHC (packaged_food) · GIS (packaged_food) · HRL (packaged_food) · MKC (packaged_food) · SJM (packaged_food) · CAG (packaged_food)

Mapping note: name-level 'Structural — GLP-1 / Private-Label Erosion' (24%) + 'Volume / Cost Recession' (18%) map to cluster Structural — GLP-1 / Private-Label Volume Hit (42%); name-level 'Growth — Snacking + Premiumization' (18%) + 'Bull — Margin Recovery / Re-Rate' (8%) map to cluster Upside — Premiumization / EM Growth (26%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.

On the cluster's key downside — Structural — GLP-1 / Private-Label Volume Hit () — this name implies 42% vs the cluster house view of 40% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The staples_food_bev cycle is the shared macro driver. Driver — food & beverage volume + price/mix vs private-label + GLP-1 + input costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Model Appendix

DCF — line items

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 4% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 8.0% · Σ PV(FCF) $3B + PV(terminal) $4B = EV $7B; + net cash → equity $1B ÷ diluted shares 0.48B = $1/share (exit-multiple terminal).

• Gordon (perpetuity-growth) terminal at 2.5% → $15/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
• Incremental ROIC on the forecast capex ≈ 5% vs WACC 8% → below WACC — the incremental build is value-dilutive.

Peer set

Peer-median fwd P/E → $27; EV/Rev → $36.

Weighted fair-value math

Sensitivity

DCF/share — WACC × terminal multiple

DCF/share — revenue CAGR Δ × op-margin Δ

Tornado — DCF/share swing by driver (widest first)

Company lever — SoP/share vs Packaged Foods multiple (AI re-rating) (base 8x)

Consensus & Market Expectations

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Balance Sheet & Liquidity

Balance-sheet data as of 2025-05-31 (Alpha Vantage).

Capital Allocation

Free-Cash-Flow Quality

Accounting quality: SBC 0.4% of revenue; cash conversion (OCF/NI) 147% — cash-backed.

Catalyst Calendar

• 2026-07-15 (~7d) — Quarterly earnings — est. EPS $0.46 (AV EARNINGS_CALENDAR)
• 2026-10-01 (~85d) — FY2027 guidance / annual outlook with GLP-1 and volume commentary (authored)
• 2026-12-15 (~160d) — Supply-chain modernisation / cost-savings program milestone (authored)
• 2027-04-01 (~267d) — Dividend declaration / payout-review decision point (authored)

Forecast Track Record

• EPS surprise: beat 50.0% of the last 8 quarters; average surprise +1.3%.

Competitive Moat

Narrow moat. The moat is brand-and-shelf-space in frozen/snacking plus retailer scale, not category dominance; with a 9.3% operating margin, ~2% growth and 10.3% dividend yield signalling distress, the terminal multiple cannot justify the packaged-food peer ~16x - if organic volume prints negative for two consecutive years the terminal multiple should hold at the current ~8x rather than re-rate, and a dividend cut would push it toward the 5x structural-impairment level.

Moat sources:

• Brand equity in frozen (Birds Eye, Healthy Choice) and snacking (Slim Jim, Angie's BOOMCHICKAPOP) portfolios
• Frozen-aisle shelf-space and retailer-relationship scale
• ABSENT: pricing power exhausted after 2022-24 inflation rounds - demand elasticity now binding
• ABSENT: no defence against private-label share gains or GLP-1 appetite suppression in core aisles

Regulatory & Legal Risk

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

What the Market Is Pricing In

At the current price, the market pays 8.8× forward EPS, vs the house DCF terminal 7.0×, and a peer median 16.56×. The house DCF sits 90% below spot, so the market is pricing in more than the house case — roughly 1.0pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.

Peer Quality & Weighting

Quality-weighted forward P/E: 15.0× (simple median 16.56×). Direct peers count 100%, segment 50%, broad 25%.

Valuation-anchor screen: DCF (exit) (excluded (>3× or <0.3× spot)); Peer (fwd P/E) (valid but extreme (>100% over median)). Anchor median 13.2. Extreme/excluded anchors carry no headline weight.

Historical-range cross-check: 52-week range $13–$20, centre $16 (+12% vs spot); spot sits at the 21th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Margin Recovery / Re-Rate): $23.

Assumption Register

Sensitivity-ranked drivers (widest fair-value swing first): Op margin ±3pp (10.0); Revenue CAGR ±3pp (4.0); Terminal × ±15% (3.0); Capex intensity ±15% (3.0); WACC ±1pp (1.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Source Log

Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.

Load-Bearing Assumptions

DCF: WACC 8%, terminal multiple 7×, FY+5 revenue $12B. Triangulation leans 41% on DCF, 29% on PWEV.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

• Organic net sales growth (y/y) < -0.5% (2 consecutive prints → Structural — GLP-1 / Private-Label Volume Hit). The base path assumes 2.0% growth; the recession path assumes -3.0%. Two prints below the midpoint indicate price/mix is no longer offsetting volume and probability weight should shift toward the recession and structural scenarios.
• Volume contribution to organic growth (y/y) < -3.0% (2 consecutive prints → Structural — GLP-1 / Private-Label Volume Hit). Sustained volume declines of this size, disclosed each quarter in the organic-growth bridge, cannot be priced away and are the direct mechanism of the GLP-1 / private-label erosion scenario.
• Adjusted operating margin < 8.7% (2 consecutive prints → Mid-Cycle — Price/Mix Offsets Volume). The base margin is 9.3% and the recession path carries 8.0%. Two prints below 8.7% mean input costs or trade spend are absorbing the recovery and the margin-recovery leg of the bull case is not available.
• Net debt > $7.0B (2 consecutive prints → Structural — GLP-1 / Private-Label Volume Hit). Net debt stands at $6.5B. Two quarters above $7.0B mean free cash flow after the dividend has turned negative and deleveraging has reversed, forcing the payout-versus-reinvestment choice the bear case turns on.
• Dividend per share action = cut or suspension announced (single event → Structural — GLP-1 / Private-Label Volume Hit). A 10.3% indicated yield is the main support under the share price. A cut removes that floor and confirms the balance sheet cannot fund both the payout and the brand reinvestment the volume defence requires.

Fact / Inference / Speculation

• FACT: Spot $14; 52-week range $13–$20; engine rating HOLD; base-case target $13 (-6%). (source: Alpha Vantage 2026-06-26, 8 July 2026)
• INFERENCE: Triangulated FV $13 (-9% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
• SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.

Recommendation: HOLD

Balanced: triangulated fair value $9.79 (-30% vs spot); the outcome hinges on Gross Margin. The debate is Gross Margin — a fundamental call.

Disclosures & Limitations

This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.

• No suitability assessment has been performed for any individual.
• Market data may be delayed or inaccurate; figures are as of the analysis date.
• Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
• Forecasts are uncertain; past performance is not indicative of future returns.
• The author or publisher may hold positions in securities mentioned.
• Users should verify information against primary sources (company filings) before acting.
• Investing involves risk of loss; there is no guarantee any target price is achieved.
• Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.